Data report · Q4 2026
Psychedelic retreats by place: price, length, screening and the law, Q4 2026
133 centres in 11 places, 92 published programme prices, and 203 recruiting clinical trials, computed from the directory's sourced rows and the ClinicalTrials.gov registry. A frozen snapshot, dated 26 Oct 2026: these numbers will not change on this page.
Free to quote with a link to this page. Prices are what centres publish, not what people pay.
Key findings
- Ibogaine is the most expensive medicine: published ibogaine programmes in Mexico have a median starting price of $8,350 ($5,500 to $15,500), about $1,250 a night against $420 for ayahuasca. See the table
- The same medicine costs more in Costa Rica: a week-long ayahuasca programme has a median published price of $3,600 there, against $2,235 in Peru. See the table
- Only 19 of 67 centres (28%) name or state a physician or nurse, and 9 publish all four of a price, medical screening, medical staff and integration support. See the table
- 11 sourced public record entries cover 8 of 133 centres, including 5 reported deaths; 3 of those deaths were at ibogaine clinics in Mexico, where 7 of 12 clinics state ECG screening. See the table
- Psilocybin is still prohibited under state law in 42 of the 50 states and DC; 29 local measures in 7 states and DC deprioritise or decriminalise it, the latest King County, Washington, in 2026. See the table
- Costa Rica's updated controlled-substance list of 10 Sep 2026 keeps psilocybin on Lista I, while 4 psilocybin retreats listed there operate openly. See the table
- 203 trials of psychedelics and ketamine were recruiting on 26 Oct 2026; 19 are in phase 3 (10 ketamine or esketamine, 7 psilocybin, 2 MDMA), 6 are industry-sponsored and none test ibogaine. See the table
Place by place
| Place and medicine | Legal footing | Centres | Price per night (median, range) | Typical length | Screening described | Public record |
|---|---|---|---|---|---|---|
| JamaicaPsilocybin | Legal | 6 | $1,049 ($833 to $1,686, 10 programmes) | 5.5 nights2 to 7 | 6 of 6 | 1 |
| NetherlandsPsilocybin (truffles) | Legal | 8 | EUR 875 (EUR 583 to EUR 1,325, 5 programmes)$1,206 ($1,063 to $1,350, 2 programmes) | 3.5 nights2 to 5 | 7 of 8 | 0 |
| Oregon, USAPsilocybin | Licensed | 2120 from the state register | Not published | Not published | Not assessed (state register) | 0 |
| Colorado, USAPsilocybin | Licensed | 4646 from the state register | Not published | Not published | Not assessed (state register) | 0 |
| PeruAyahuasca | Legal | 13 | S/ 714 (1 programme)$340 ($142 to $476, 9 programmes) | 7 nights5 to 20 | 11 of 13 | 2 |
| Costa RicaAyahuasca | Tolerated | 13 | $614 ($198 to $1,275, 12 programmes) | 6 nights2 to 12 | 8 of 13 | 1 |
| Costa RicaPsilocybin | Illegal but tolerated in practice | 4 | EUR 1,000 (EUR 813 to EUR 1,225, 3 programmes)$767 (1 programme) | 3.5 nights2 to 4 | 4 of 4 | 0 |
| BrazilAyahuasca | Religious use only | 4 | $291 ($275 to $306, 2 programmes) | 8 nights7 to 10 | 0 of 4 | 0 |
| MexicoIbogaine | Unregulated | 12 | $1,250 ($1,071 to $2,214, 9 programmes) | 7 nights4 to 14 | 11 of 12 | 4 |
| MexicoPsilocybin | Illegal but tolerated in practice | 3 | $1,099 ($1,032 to $1,167, 2 programmes) | 6.5 nights6 to 7 | 3 of 3 | 0 |
| PortugalPsilocybin | Illegal but tolerated in practice | 3 | EUR 663 (2 programmes)GBP 430 (1 programme) | 5 nights3 to 6 | 3 of 3 | 0 |
What a whole programme costs
Price per night hides how long programmes run. Here is the published starting price of a whole programme, by place and medicine. The most common lengths are 6 and 7 nights (12 and 12 programmes), so the "about a week" column takes programmes of 6 or 7 nights. Currencies are never converted.
| Place and medicine | Any length (median, range) | About a week, 6 or 7 nights |
|---|---|---|
| JamaicaPsilocybin | $5,525 ($2,250 to $11,800, 10 programmes) | $6,650 ($4,995 to $11,800, 6 programmes) |
| NetherlandsPsilocybin (truffles) | EUR 2,650 (EUR 1,750 to EUR 3,750, 5 programmes)$5,500 ($4,250 to $6,750, 2 programmes) | None at this length |
| PeruAyahuasca | S/ 5,000 (1 programme)$2,520 ($850 to $6,800, 9 programmes) | S/ 5,000 (1 programme)$2,235 ($850 to $3,330, 4 programmes) |
| Costa RicaAyahuasca | $3,138 ($1,190 to $7,650, 12 programmes) | $3,600 ($1,190 to $7,650, 7 programmes) |
| Costa RicaPsilocybin | EUR 3,250 (EUR 2,450 to EUR 3,999, 3 programmes)$2,300 (1 programme) | None at this length |
| BrazilAyahuasca | $2,600 ($2,450 to $2,750, 2 programmes) | None at this length |
| MexicoIbogaine | $8,350 ($5,500 to $15,500, 9 programmes) | $10,750 ($8,000 to $15,500, 4 programmes) |
| MexicoPsilocybin | $7,113 ($7,000 to $7,225, 2 programmes) | $7,113 ($7,000 to $7,225, 2 programmes) |
| PortugalPsilocybin | EUR 1,990 (EUR 1,990 to EUR 1,990, 2 programmes)GBP 2,150 (1 programme) | None at this length |
By medicine, US dollar prices, every place
| Medicine | Programme (median, range) | About a week, 6 or 7 nights | Per night (median) |
|---|---|---|---|
| Ayahuasca | $2,750 ($850 to $7,650, 23) | $3,300 ($850 to $7,650, 11) | $420 |
| Psilocybin | $5,550 ($2,250 to $11,800, 15) | $6,900 ($4,995 to $11,800, 8) | $1,063 |
| Ibogaine | $8,350 ($5,500 to $15,500, 9) | $10,750 ($8,000 to $15,500, 4) | $1,250 |
Each programme's published price divided by its published nights. Places where fewer than 3 programmes are priced in dollars are marked. Euro and other prices are in the table above, never converted.
Cheapest and most expensive published residential programmes, US dollars
Programmes of at least 2 nights or 3 days, one per centre. Single ceremonies and day rates are left out.
| Centre | Programme | Published from | Source |
|---|---|---|---|
| KapitariPeru, Ayahuasca | 7-day retreat (6 nights) | $850 | Centre's page |
| Ayaterra Costa RicaCosta Rica, Ayahuasca | 7 days / 6 nights (6 nights) | $1,190 | Centre's page |
| The Healing Tree Center (Costa Rica)Costa Rica, Ayahuasca | 3 days / 2 nights (2 nights) | $1,400 | Centre's page |
| Transcend ClinicMexico, Ibogaine | 21-day program (21 days) | $36,000 | Centre's page |
| BeondMexico, Ibogaine | 7-day Transitions program (7 nights) | $15,500 | Centre's page |
| Iboga Wellness InstituteMexico, Ibogaine | Neurological - chronic conditions (14 nights) | $15,000 | Centre's page |
First 3 rows: cheapest. Last 3: most expensive. Out of 51 dollar-priced programmes, prices as published on the dates shown on each centre's profile.
What centres disclose
Out of the 67 centres whose own websites we read (66 more in Oregon and Colorado are listed from the state registers and not counted here), how many publish each thing a careful buyer would look for.
Counted from each centre's published pages as recorded on its profile. A centre that does a thing without saying so is counted as not disclosing it.
By place
| Place and medicine | Price | Medical screening | Physician or nurse | Integration support | Antidepressant screening |
|---|---|---|---|---|---|
| JamaicaPsilocybin | 5 of 6 | 6 of 6 | 2 of 6 | 6 of 6 | Not assessed |
| NetherlandsPsilocybin (truffles) | 6 of 8 | 7 of 8 | 3 of 8 | 7 of 8 | Not assessed |
| Oregon, USAPsilocybin | 0 of 1 | 0 of 1 | 0 of 1 | 0 of 1 | Not assessed |
| PeruAyahuasca | 12 of 13 | 11 of 13 | 3 of 13 | 4 of 13 | 11 of 13 |
| Costa RicaAyahuasca | 9 of 13 | 8 of 13 | 1 of 13 | 8 of 13 | 9 of 13 |
| Costa RicaPsilocybin | 4 of 4 | 4 of 4 | 1 of 4 | 4 of 4 | 3 of 4 |
| BrazilAyahuasca | 1 of 4 | 0 of 4 | 0 of 4 | 1 of 4 | 2 of 4 |
| MexicoIbogaine | 6 of 12 | 11 of 12 | 8 of 12 | 5 of 12 | Not assessed |
| MexicoPsilocybin | 3 of 3 | 3 of 3 | 1 of 3 | 3 of 3 | 3 of 3 |
| PortugalPsilocybin | 2 of 3 | 3 of 3 | 0 of 3 | 3 of 3 | 1 of 3 |
By medicine
| Medicine | Price | Medical screening | Physician or nurse | Integration support | Antidepressant screening |
|---|---|---|---|---|---|
| Ayahuasca | 22 of 30 | 19 of 30 | 4 of 30 | 13 of 30 | 22 of 30 |
| Psilocybin | 20 of 25 | 23 of 25 | 7 of 25 | 23 of 25 | 7 of 10 |
| Ibogaine | 6 of 12 | 11 of 12 | 8 of 12 | 5 of 12 | Not assessed |
| All | 48 of 67 | 53 of 67 | 19 of 67 | 41 of 67 | 29 of 40 |
Antidepressant screening is recorded only for ayahuasca centres and for psilocybin centres in Costa Rica, Mexico and Portugal; elsewhere it was not assessed.
What a careful buyer can find out
- A starting price, for 48 of 67 centres.
- Whether the centre screens for medical conditions, for 53.
- The legal footing of the medicine where the centre operates, for every centre, from cited law.
- Any reported death, regulator action, legal case or allegation we found, with its sources.
What they cannot
- What people actually pay: we record only published starting prices.
- Refund and cancellation terms: we did not record them for every centre, so this report gives no figure.
- Who is on site at a given ceremony: 48 of 67 centres do not name or state a physician or nurse.
- Outcome or incident rates: none are recorded in our rows, so this report gives none.
The safety record
11 dated, sourced public record entries at 8 of 133 centres. An entry is a reported death, a regulator action, a legal or criminal case, or a published allegation, as reported by the sources named on the centre's profile. It is not a finding of fault.
| Type | Entries |
|---|---|
| Reported death | 5 |
| Legal case | 2 |
| Published allegation | 2 |
| Criminal case | 1 |
| Regulator action | 1 |
| Place and medicine | Entries |
|---|---|
| Mexico, Ibogaine | 5 |
| Costa Rica, Ayahuasca | 3 |
| Peru, Ayahuasca | 2 |
| Jamaica, Psilocybin | 1 |
| Date | Type | Centre | Place | Source |
|---|---|---|---|---|
| 2026-01-24 | Criminal case | Transcend Clinic | Mexico, Ibogaine | Source |
| 2026-01-21 | Reported death | Ambio Life Sciences | Mexico, Ibogaine | Source |
| 2025-02-17 | Regulator action | Rythmia Life Advancement Center | Costa Rica, Ayahuasca | Source |
| 2025-01 | Reported death | The Ayahuasca Foundation | Peru, Ayahuasca | Source |
| 2025 | Reported death | IbogaQuest | Mexico, Ibogaine | Source |
| 2023-03 | Legal case | Beond | Mexico, Ibogaine | Source |
| 2022-06-23 | Published allegation | Rythmia Life Advancement Center | Costa Rica, Ayahuasca | Source |
| 2022-05-08 | Reported death | Beond | Mexico, Ibogaine | Source |
| 2022 | Legal case | Rythmia Life Advancement Center | Costa Rica, Ayahuasca | Source |
| 2020-06 | Published allegation | MycoMeditations | Jamaica, Psilocybin | Source |
| 2015-09 | Reported death | Kapitari | Peru, Ayahuasca | Source |
Ibogaine clinics in Mexico: cardiac screening
Ibogaine is linked to dangerous heart-rhythm changes, so ECG screening and cardiac monitoring are the first questions to ask. Of 12 ibogaine clinics listed in Mexico:
| The clinic's published pages | Clinics |
|---|---|
| State ECG screening before treatment | 7 of 12 |
| State continuous cardiac monitoring during treatment | 8 of 12 |
| Name or state a physician or nurse | 8 of 12 |
| Claim medical staff without naming a physician or nurse | 3 of 12 |
| Have a public record entry | 4 of 12 |
Legal map
Every place and medicine we hold a cited legal entry for: 37 rows, each with its source on the Legal page. "Illegal but tolerated in practice" means the medicine is illegal and retreats operate openly with no prosecution of one that we could find.
| Place | Medicine | Status |
|---|---|---|
| Colorado, USA | Psilocybin | Licensed |
| Oregon, USA | Psilocybin | Licensed |
| International | Psychedelic plants | Unscheduled |
| Jamaica | Psilocybin | Unscheduled |
| Netherlands | Psilocybin truffles | Unscheduled |
| Mexico | Ibogaine | Unregulated |
| Peru | Ayahuasca | Unregulated |
| Brazil | Ayahuasca | Religious use only |
| Costa Rica | Psilocybin | Illegal but tolerated in practice |
| Mexico | Psilocybin | Illegal but tolerated in practice |
| Portugal | Psilocybin | Illegal but tolerated in practice |
| Australia | Psilocybin | Medical only |
| Canada | Psilocybin | Medical only |
| Czech Republic | Psilocybin | Medical only |
| Germany | Psilocybin | Medical only |
| New Mexico, USA | Psilocybin | Medical only |
| United States | Ketamine | Medical only |
| Colombia | Ayahuasca | Ambiguous |
| Costa Rica | Ayahuasca | Ambiguous |
| Costa Rica | Ibogaine | Ambiguous |
| Ecuador | Ayahuasca | Ambiguous |
| Spain | Ayahuasca | Ambiguous |
| The Bahamas | Psilocybin | Ambiguous |
| Colorado, USA | Peyote | Scheduled (controlled) |
| Mexico | Peyote | Scheduled (controlled) |
| Mexico | DMT | Scheduled (controlled) |
| United States | Psilocybin | Scheduled (controlled) |
| United States | DMT | Scheduled (controlled) |
| United States | Ibogaine | Scheduled (controlled) |
| United States | MDMA | Scheduled (controlled) |
| Brazil | Psilocybin | Prohibited |
| Netherlands | Psilocybin mushrooms | Prohibited |
| Peru | Psilocybin | Prohibited |
| Spain | Psilocybin | Prohibited |
| Texas, USA | Ibogaine | Prohibited |
| United Kingdom | Psilocybin | Prohibited |
| United States | Peyote | Prohibited |
Psilocybin in the 50 states and DC
Psilocybin is prohibited under state law in 42 of 51 (the 50 states and DC). The others: Colorado (licensed (adult use)), Connecticut (research programme only), Indiana (research programme only), Louisiana (research programme only), New Jersey (decriminalised), New Mexico (medical programme), Oregon (licensed (adult use)), Utah (medical programme), Washington (research programme only). Federal law still lists it in Schedule I everywhere. On top of that, 29 local measures in 7 states and DC make psilocybin or entheogenic plants a lowest enforcement priority or decriminalise them (2 in 2024, 1 in 2025, 1 in 2026). Each is cited on the psilocybin law tracker, checked 26 Oct 2026.
| Local measure | State | Year |
|---|---|---|
| Denver | Colorado | 2019 |
| Oakland | California | 2019 |
| Ann Arbor | Michigan | 2020 |
| District of Columbia | District of Columbia | 2020 |
| Santa Cruz | California | 2020 |
| Arcata | California | 2021 |
| Cambridge | Massachusetts | 2021 |
| Detroit | Michigan | 2021 |
| Easthampton | Massachusetts | 2021 |
| Northampton | Massachusetts | 2021 |
| Port Townsend | Washington | 2021 |
| Seattle | Washington | 2021 |
| Somerville | Massachusetts | 2021 |
| Washtenaw County | Michigan | 2021 |
| Amherst | Massachusetts | 2022 |
| Hazel Park | Michigan | 2022 |
| San Francisco | California | 2022 |
| Berkeley | California | 2023 |
| Eureka | California | 2023 |
| Ferndale | Michigan | 2023 |
| Jefferson County | Washington | 2023 |
| Minneapolis | Minnesota | 2023 |
| Portland | Maine | 2023 |
| Provincetown | Massachusetts | 2023 |
| Salem | Massachusetts | 2023 |
| Olympia | Washington | 2024 |
| Ypsilanti | Michigan | 2024 |
| Tacoma | Washington | 2025 |
| King County | Washington | 2026 |
What changed in 2026
The law-change log holds 28 dated changes (reviewed 11 Oct 2026). 2 are dated 2026:
- 10 Sep 2026, Costa Rica. The Ministry of Health published an updated list of substances under national control, under Reglamento 45161-S. Psilocybin and psilocin remain on Lista I of psychotropic substances, as in the October 2022 edition. Source
- 1 Jan 2026, the Czech Republic. The psilocybin provisions of Act No. 270/2025 Coll. took effect. Psilocybin for medical use may be given only by a psychiatrist, under supervision, to patients over 18 in Ministry of Health psychiatric hospitals and hospital psychiatric departments licensed by the Ministry. The clinical guideline limits it to depression associated with cancer, clinically severe depression where prior treatment failed, and other severe life-threatening disorders where usual treatment fails. Retreat and recreational use remain illegal. Source
Changes logged per year: 2020: 1, 2021: 1, 2022: 3, 2023: 4, 2024: 5, 2025: 6, 2026: 2. Feed
The research pipeline
203 trials were recruiting on ClinicalTrials.gov on 26 Oct 2026, at sites in 31 countries and 32 US states. 19 are in phase 3 or a combined phase 2 and 3. 6 are sponsored by industry; 182 fall in the registry's "other" sponsor class (universities, hospitals and individual investigators). No recruiting trial tests ibogaine.
Phase as registered. "Not applicable" is how the registry marks studies without a drug-development phase. 203 trials in all.
By condition
| Condition | Trials |
|---|---|
| Depression | 86 |
| PTSD | 29 |
| Opioid use disorder | 14 |
| Cancer and end-of-life distress | 14 |
| Anxiety | 13 |
| Alcohol use disorder | 12 |
| OCD | 8 |
| Bipolar disorder | 6 |
| Eating disorders | 3 |
| Smoking and nicotine | 2 |
| Cocaine and methamphetamine | 2 |
| Gambling | 1 |
| Other or unclassified | 52 |
A trial can study more than one condition.
By substance
| Substance | Trials | Phase 3 |
|---|---|---|
| Psilocybin | 102 | 7 |
| Ketamine / esketamine | 72 | 10 |
| MDMA | 23 | 2 |
| DMT / ayahuasca | 11 | 0 |
| LSD | 6 | 0 |
| 5-MeO-DMT | 1 | 0 |
Top sponsors
| Sponsor | Trials |
|---|---|
| Johns Hopkins University | 13 |
| Yale University | 12 |
| University Hospital, Basel, Switzerland | 9 |
| Centre for Addiction and Mental Health | 4 |
| Icahn School of Medicine at Mount Sinai | 4 |
| NYU Langone Health | 4 |
US states with the most trials
| State | Trials with a site there |
|---|---|
| Maryland | 23 |
| New York | 19 |
| California | 17 |
| Connecticut | 14 |
| Texas | 11 |
| Georgia | 8 |
| Massachusetts | 7 |
| Pennsylvania | 6 |
Method
- What was counted: 133 centres in 11 places listed in the Peyote.com directory on 26 Oct 2026, each with its sources on its profile, and the 203 trials marked recruiting on ClinicalTrials.gov on 26 Oct 2026 whose interventions name psilocybin, MDMA, ketamine or esketamine, ibogaine, DMT or ayahuasca, 5-MeO-DMT, LSD or mescaline.
- Dates: centre pages were read in September and October 2026, latest 2026-10-26; each price carries its own as-of date on the centre's profile. The snapshot is frozen: these numbers will not change on this page.
- Prices: the published starting price of a programme, never what anyone paid. Price per night is that price divided by its published nights; programmes without both, or priced per ceremony or per day, are left out of per-night figures. "About a week" means 6 or 7 nights, the two most common lengths. Currencies are never converted.
- Disclosure: counted only for centres whose own website we read. State-licensed centres in Oregon and Colorado are listed from the state registers, not their websites, so they are excluded. "A physician or nurse" means the centre's pages, or press its profile cites, name or state a physician or nurse on staff or present; vague claims of "medical professionals" are not counted. "Integration support" means integration appears in the centre's published inclusions, programme names or description.
- Public record: dated entries (a reported death, regulator action, legal or criminal case, or published allegation) on a centre's profile, each with its sources. It is what was reported, not a finding of fault, and the absence of an entry is not evidence of safety.
- Legal map: the cited entries behind the Legal page, and the dated law-change log. "Illegal but tolerated in practice" is defined there with its enforcement searches.
- Caveats: the directory is not a census of every retreat, so counts describe the listed centres only. Small groups (fewer than 5 programmes or centres) are shown with their counts and should not be read as market-wide.
How to cite
Peyote.com, "Psychedelic retreats by place: price, length, screening and the law, Q4 2026", data report, 26 Oct 2026. https://peyote.com/reports/2026-q4
The data is free to reuse under CC BY 4.0 with a link to this page. Every table on this page is in one CSV file; the live, row-level data is at /data. Questions: hello@peyote.com.
Download the PDF
The full report as a PDF, with the tables, charts and method. Everything in it is also on this page, free.
Loading the form.